Prenetics Global Limited (PRENW) Stock Price & Analysis
Prenetics Global Limited (PRENW) closed at USD 0.01 on Tuesday, October 13, 2026, up 0.00% on the day. The US market is currently closed; this is not a live price.
The prior close was USD 0.01; the Oct 13, 2026 session ranged USD 0.01–0.01 on volume of 0 shares. Market capitalization is —, with a 52-week range of USD 0.01–0.01 (NCM). Source: Nexqual, retrieved October 16, 2026 at 05:49 UTC.
Also available as compact Markdown for AI agents: nexqual.com/PRENW.md
Key facts (PRENW)
- Analysts: None.
Analysts (PRENW)
Consensus None.
Key Statistics (as of October 16, 2026 at 05:49 UTC)
| Price | USD 0.01 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0.01 |
| Open | USD 0.02 |
| Day Range | USD 0.01 – 0.01 |
| 52-Week Range | USD 0.01 – 0.01 |
| Volume | 0 shares |
| Market Cap | — |
| Exchange | NCM |
Analyst Ratings (PRENW)
Wall Street analysts rate PRENW "None", per Nexqual as of October 16, 2026 at 05:49 UTC.
| Consensus Rating | None |
|---|
Earnings (PRENW)
| Revenue Estimate | $63.13M |
|---|
Source: Nexqual, October 16, 2026 at 05:49 UTC.
Financials & Fundamentals (PRENW)
| Total Revenue | $154.59M |
|---|---|
| Revenue Growth (latest quarter, YoY) | +210.70% |
| Gross Margin | +57.77% |
| Operating Margin | -45.13% |
| Profit Margin | -30.40% |
| ROE | -47.01% |
| Debt / Equity | 0.01 |
| Current Ratio | 4.04 |
| Total Cash | $128.56M |
| Total Debt | $682,000 |
Source: Nexqual, October 16, 2026 at 05:49 UTC.
Financial Health Score (PRENW)
Nexqual rates Prenetics Global Limited's overall financial health "Mixed" across five dimensions, as of October 16, 2026 at 05:49 UTC.
| Growth | Strong — Revenue +202% YoY (annual) |
|---|---|
| Profitability | Mixed — Gross margin 58%, operating -45% |
| Balance Sheet | Strong — $129M cash, no debt |
| Cash Flow | Weak — Operating cash flow -$40M (TTM) |
| Efficiency | Critical — ROE -47%, ROA -18.9% |
Ownership (PRENW)
| Float | 12.78M |
|---|
Source: Nexqual, October 16, 2026 at 05:49 UTC.
Leadership (PRENW)
Prenetics Global Limited is led by Sheng Wu Yeung (age 46), Co-Founder, Chairperson & CEO, per Nexqual as of October 16, 2026 at 05:49 UTC.
| Co-Founder, Chairperson & CEO | Sheng Wu Yeung (age 46) |
|---|---|
| Chief Financial Officer of U.S. | Brian J. Rosin |
Major Backers & Investors (PRENW)
Notable institutional backers of Prenetics Global Limited include LMR Partners LLP, Aspex Management (HK) Ltd, Nine Masts Capital Ltd., according to Nexqual as of October 16, 2026 at 05:49 UTC.
Active Investors
| Investor | Stake |
|---|---|
| LMR Partners LLP | 11.53% |
| Aspex Management (HK) Ltd | 10.31% |
| Nine Masts Capital Ltd. | 3.2% |
| Calamos Advisors LLC | 1.77% |
| Shaw D.E. & Co., Inc. | 0.92% |
| Jane Street Group, LLC | 0.73% |
| Vestcor Inc | 0.59% |
| Peak6 LLC | 0.59% |
Source: Nexqual, October 16, 2026 at 05:49 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| PIIIW | P3 Health Partners Inc. | USD 0.01 | ▲ 16.67% |
| REVBW | Revelation Biosciences, Inc. | USD 0.01 | ▲ 1.56% |
| OABIW | OmniAb, Inc. | USD 0.25 | ▼ 13.58% |
| PGYWW | Pagaya Technologies Ltd. Warran | USD 0.01 | ▲ 24.56% |
| DRTSW | Alpha Tau Medical Ltd. Warrant | USD 2.99 | ▼ 17.4% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 16, 2026 at 05:49 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt